These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28043903)

  • 1. In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.
    Vergis N; Atkinson SR; Knapp S; Maurice J; Allison M; Austin A; Forrest EH; Masson S; McCune A; Patch D; Richardson P; Gleeson D; Ryder SD; Wright M; Thursz MR
    Gastroenterology; 2017 Apr; 152(5):1068-1077.e4. PubMed ID: 28043903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial.
    Thursz M; Forrest E; Roderick P; Day C; Austin A; O'Grady J; Ryder S; Allison M; Gleeson D; McCune A; Patch D; Wright M; Masson S; Richardson P; Vale L; Mellor J; Stanton L; Bowers M; Ratcliffe I; Downs N; Kirkman S; Homer T; Ternent L
    Health Technol Assess; 2015 Dec; 19(102):1-104. PubMed ID: 26691209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisolone or pentoxifylline for alcoholic hepatitis.
    Thursz MR; Richardson P; Allison M; Austin A; Bowers M; Day CP; Downs N; Gleeson D; MacGilchrist A; Grant A; Hood S; Masson S; McCune A; Mellor J; O'Grady J; Patch D; Ratcliffe I; Roderick P; Stanton L; Vergis N; Wright M; Ryder S; Forrest EH;
    N Engl J Med; 2015 Apr; 372(17):1619-28. PubMed ID: 25901427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.
    Mathurin P; Louvet A; Duhamel A; Nahon P; Carbonell N; Boursier J; Anty R; Diaz E; Thabut D; Moirand R; Lebrec D; Moreno C; Talbodec N; Paupard T; Naveau S; Silvain C; Pageaux GP; Sobesky R; Canva-Delcambre V; Dharancy S; Salleron J; Dao T
    JAMA; 2013 Sep; 310(10):1033-41. PubMed ID: 24026598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial.
    Forrest E; Mellor J; Stanton L; Bowers M; Ryder P; Austin A; Day C; Gleeson D; O'Grady J; Masson S; McCune A; Patch D; Richardson P; Roderick P; Ryder S; Wright M; Thursz M
    Trials; 2013 Aug; 14():262. PubMed ID: 23958271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical Trial.
    Louvet A; Labreuche J; Dao T; Thévenot T; Oberti F; Bureau C; Paupard T; Nguyen-Khac E; Minello A; Bernard-Chabert B; Anty R; Wartel F; Carbonell N; Pageaux GP; Hilleret MN; Moirand R; Nahon P; Potey C; Duhamel A; Mathurin P
    JAMA; 2023 May; 329(18):1558-1566. PubMed ID: 37159035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.
    Louvet A; Thursz MR; Kim DJ; Labreuche J; Atkinson SR; Sidhu SS; O'Grady JG; Akriviadis E; Sinakos E; Carithers RL; Ramond MJ; Maddrey WC; Morgan TR; Duhamel A; Mathurin P
    Gastroenterology; 2018 Aug; 155(2):458-468.e8. PubMed ID: 29738698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Garcia-Saenz-de-Sicilia M; Duvoor C; Altamirano J; Chavez-Araujo R; Prado V; de Lourdes Candolo-Martinelli A; Holanda-Almeida P; Becerra-Martins-de-Oliveira B; Fernandez-de-Almeida S; Bataller R; Caballeria J; Duarte-Rojo A
    Am J Gastroenterol; 2017 Feb; 112(2):306-315. PubMed ID: 27922027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.
    Atkinson SR; Grove JI; Liebig S; Astbury S; Vergis N; Goldin R; Quaglia A; Bantel H; Guha IN; Thursz MR; Newcombe P; Strnad P; Aithal GP
    Am J Gastroenterol; 2020 Nov; 115(11):1857-1868. PubMed ID: 33156105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Granulocyte Colony-stimulating Factor in the Management of Steroid-Nonresponsive Severe Alcoholic Hepatitis: A Double-Blind Randomized Controlled Trial.
    Shasthry SM; Sharma MK; Shasthry V; Pande A; Sarin SK
    Hepatology; 2019 Sep; 70(3):802-811. PubMed ID: 30664267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial.
    De BK; Gangopadhyay S; Dutta D; Baksi SD; Pani A; Ghosh P
    World J Gastroenterol; 2009 Apr; 15(13):1613-9. PubMed ID: 19340904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis.
    Forrest EH; Storey N; Sinha R; Atkinson SR; Vergis N; Richardson P; Masson S; Ryder S; Thursz MR; Allison M; Fraser A; Austin A; McCune A; Dhanda A; Katarey D; Potts J; Verma S; Parker R; Hayes PC;
    Aliment Pharmacol Ther; 2019 Aug; 50(4):442-453. PubMed ID: 31313853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial.
    Park SH; Kim DJ; Kim YS; Yim HJ; Tak WY; Lee HJ; Sohn JH; Yoon KT; Kim IH; Kim HS; Um SH; Baik SK; Lee JS; Suk KT; Kim SG; Suh SJ; Park SY; Kim TY; Jang JY;
    J Hepatol; 2014 Oct; 61(4):792-8. PubMed ID: 24845609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
    Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
    Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.
    Gawrieh S; Dasarathy S; Tu W; Kamath PS; Chalasani NP; McClain CJ; Bataller R; Szabo G; Tang Q; Radaeva S; Barton B; Nagy LE; Shah VH; Sanyal AJ; Mitchell MC;
    J Hepatol; 2024 May; 80(5):684-693. PubMed ID: 38342441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New paradigms in management of alcoholic hepatitis: a review.
    Sidhu SS; Goyal O; Kishore H; Sidhu S
    Hepatol Int; 2017 May; 11(3):255-267. PubMed ID: 28247264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial).
    Sidhu SS; Goyal O; Singla P; Gupta D; Sood A; Chhina RS; Soni RK
    Dig Dis Sci; 2012 Jun; 57(6):1664-71. PubMed ID: 22388710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of long-term outcome in severe alcoholic hepatitis.
    Potts JR; Goubet S; Heneghan MA; Verma S
    Aliment Pharmacol Ther; 2013 Sep; 38(6):584-95. PubMed ID: 23879720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of compromised urea synthesis in patients with alcoholic hepatitis.
    Glavind E; Aagaard NK; Gronbaek H; Orntoft NW; Vilstrup H; Thomsen KL
    Scand J Gastroenterol; 2018 May; 53(5):592-597. PubMed ID: 29113530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis.
    Philips CA; Phadke N; Ganesan K; Ranade S; Augustine P
    Indian J Gastroenterol; 2018 May; 37(3):215-225. PubMed ID: 29931479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.